122 related articles for article (PubMed ID: 31980342)
1. Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states.
Glenthøj LB; Kristensen TD; Wenneberg C; Hjorthøj C; Nordentoft M
Schizophr Res; 2020 Apr; 218():151-156. PubMed ID: 31980342
[TBL] [Abstract][Full Text] [Related]
2. Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.
Schlosser DA; Campellone TR; Biagianti B; Delucchi KL; Gard DE; Fulford D; Stuart BK; Fisher M; Loewy RL; Vinogradov S
Schizophr Res; 2015 Dec; 169(1-3):204-208. PubMed ID: 26530628
[TBL] [Abstract][Full Text] [Related]
3. Predictors of remission from the ultra-high risk state for psychosis.
Glenthøj LB; Kristensen TD; Wenneberg C; Hjorthøj C; Nordentoft M
Early Interv Psychiatry; 2021 Feb; 15(1):104-112. PubMed ID: 31910496
[TBL] [Abstract][Full Text] [Related]
4. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
[TBL] [Abstract][Full Text] [Related]
5. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.
Meyer EC; Carrión RE; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Heinssen R; Seidman LJ;
Schizophr Bull; 2014 Nov; 40(6):1452-61. PubMed ID: 24550526
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Psychosocial Functioning and Outcome of Individuals With Recent-Onset Schizophrenia and at Ultra-High Risk for Psychosis.
Kim HK; Park HY; Seo E; Bang M; Song YY; Lee SY; Kim KR; Park JY; Kang JI; Lee E; An SK
Front Psychiatry; 2019; 10():459. PubMed ID: 31293463
[No Abstract] [Full Text] [Related]
7. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis.
Glenthøj LB; Jepsen JR; Hjorthøj C; Bak N; Kristensen TD; Wenneberg C; Krakauer K; Nordentoft M; Fagerlund B
Acta Psychiatr Scand; 2017 Mar; 135(3):250-258. PubMed ID: 27988937
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
[TBL] [Abstract][Full Text] [Related]
9. Basic symptoms influence real-life functioning and symptoms in individuals at high risk for psychosis.
Glenthøj LB; Bailey B; Kristensen TD; Wenneberg C; Hjorthøj C; Nordentoft M
Acta Psychiatr Scand; 2020 Mar; 141(3):231-240. PubMed ID: 31621062
[TBL] [Abstract][Full Text] [Related]
10. The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
Strauss GP; Macdonald KI; Ruiz I; Raugh IM; Bartolomeo LA; James SH
Eur Arch Psychiatry Clin Neurosci; 2022 Feb; 272(1):17-27. PubMed ID: 33881621
[TBL] [Abstract][Full Text] [Related]
11. Social skills, negative symptoms and real-world functioning in individuals at ultra-high risk of psychosis.
Lim K; Rapisarda A; Keefe RSE; Lee J
Asian J Psychiatr; 2022 Mar; 69():102996. PubMed ID: 35026654
[TBL] [Abstract][Full Text] [Related]
12. Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.
Gupta T; Cowan HR; Strauss GP; Walker EF; Mittal VA
Schizophr Bull; 2021 Jan; 47(1):54-63. PubMed ID: 32955097
[TBL] [Abstract][Full Text] [Related]
13. Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.
Hauke DJ; Schmidt A; Studerus E; Andreou C; Riecher-Rössler A; Radua J; Kambeitz J; Ruef A; Dwyer DB; Kambeitz-Ilankovic L; Lichtenstein T; Sanfelici R; Penzel N; Haas SS; Antonucci LA; Lalousis PA; Chisholm K; Schultze-Lutter F; Ruhrmann S; Hietala J; Brambilla P; Koutsouleris N; Meisenzahl E; Pantelis C; Rosen M; Salokangas RKR; Upthegrove R; Wood SJ; Borgwardt S;
Transl Psychiatry; 2021 May; 11(1):312. PubMed ID: 34031362
[TBL] [Abstract][Full Text] [Related]
14. Changes in core beliefs over time predict symptoms and functioning in clinical high risk for psychosis.
Patton HN; Cowan HR; Mittal VA
Early Interv Psychiatry; 2022 Mar; 16(3):311-315. PubMed ID: 33938147
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
[TBL] [Abstract][Full Text] [Related]
16. Perceived stress mediates the relationship between social adaptation and quality of life in individuals at ultra high risk of psychosis.
Ortega L; Montalvo I; Monseny R; Vilella E; Labad J
Early Interv Psychiatry; 2019 Dec; 13(6):1447-1454. PubMed ID: 30690915
[TBL] [Abstract][Full Text] [Related]
17. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
[TBL] [Abstract][Full Text] [Related]
19. Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.
Azis M; Strauss GP; Walker E; Revelle W; Zinbarg R; Mittal V
Schizophr Bull; 2019 Sep; 45(5):1042-1050. PubMed ID: 30535399
[TBL] [Abstract][Full Text] [Related]
20. Expressive deficits and amotivation as mediators of the associations between cognitive problems and functional outcomes: Results from two independent cohorts.
Liemburg EJ; Enriquez-Geppert S; Wardenaar KJ; Bruggeman R; Aleman A; ;
Schizophr Res; 2020 Apr; 218():283-291. PubMed ID: 31948899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
